Assoc. Prof. Dr. Iulia Ioan | Medicine | Women Researcher Award

Published on by Academic Achievements

Assoc. Prof. Dr. Iulia Ioan | Medicine | Women Researcher Award

Assoc. Prof. Dr. Iulia Ioan | Medicine – University Hospital of Nancy, France

Dr. Iulia Ioan is a dedicated researcher specializing in pediatric respiratory medicine and sleep disorders. Her work focuses on advancing the understanding and clinical management of respiratory oscillometry, asthma, and obstructive sleep apnea in children and adults. Over recent years, she has established herself as a respected figure in her field, contributing to multidisciplinary collaborations that bridge clinical practice and functional respiratory research. Her continuous output of high-quality research articles and reviews reflects her commitment to improving respiratory health outcomes through innovative diagnostics and treatment strategies.\

Profile Verified:

ORCID | Scopus | Google Scholar

Education:

Dr. Ioan’s academic journey includes advanced medical and scientific training culminating in an MD and PhD, equipping her with a solid foundation in clinical medicine and biomedical research. Her specialized education in functional respiratory explorations has enabled her to develop expertise in pediatric respiratory function testing and clinical sleep medicine, which underpins her research endeavors.

Experience:

With substantial experience in clinical and research settings, Dr. Ioan currently serves at the Service d’Explorations Fonctionnelles Pédiatriques, Hôpital d’Enfants, CHRU de Nancy. Her role involves both direct patient care and leading research projects focused on pediatric respiratory diseases and sleep disorders. Over the years, she has honed skills in polysomnography, respiratory mechanics, and the evaluation of airway diseases, collaborating with national and international teams. Her involvement in translational research facilitates the implementation of novel diagnostic tools into routine clinical practice.

Research Interest:

Dr. Ioan’s research interests encompass respiratory oscillometry, pediatric asthma, sleep apnea syndromes, and the impact of environmental factors such as tobacco smoke on respiratory health. She explores the clinical applications of respiratory function testing technologies and their relevance in diagnosing and managing obstructive airway diseases. Additionally, her work addresses the epidemiology and treatment effectiveness of severe allergic asthma and sleep-related breathing disorders, contributing valuable insights into pediatric pulmonology and sleep medicine.

Awards:

While specific awards are not listed, Dr. Ioan’s profile demonstrates recognition through citations and sustained research output. Her work’s impact on clinical practice and respiratory medicine positions her as a strong candidate for research awards celebrating female scientists. Continued excellence in publication, collaboration, and clinical innovation further strengthens her candidacy for prestigious honors within respiratory and pediatric research communities.

Selected Publications:

  1. 🌬️ “Technical standards for respiratory oscillometry,” European Respiratory Journal, 2020. (Cited by 578) – This pivotal article defines technical guidelines widely used in respiratory function testing.
  2. 💤 “Clinical significance and applications of oscillometry,” European Respiratory Review, 2022. (Cited by 168) – A comprehensive review highlighting oscillometry’s role in respiratory disease assessment.
  3. 🌟 “Asthma and obstructive sleep apnoea in adults and children – an up-to-date review,” Sleep Medicine Reviews, 2022. (Cited by 65) – Integrates current knowledge on the overlap between asthma and sleep apnea.
  4. 🚭 “The impact of tobacco smoking on adult asthma outcomes,” International Journal of Environmental Research and Public Health, 2021. (Cited by 59) – Examines how smoking exacerbates asthma symptoms and treatment outcomes.
  5. 🛌 “Feasibility of parent-attended ambulatory polysomnography in children with suspected obstructive sleep apnea,” Journal of Clinical Sleep Medicine, 2020. (Cited by 31) – Demonstrates the practicality of home-based sleep studies for children.
  6. 🌿 “Real-life effectiveness of benralizumab, mepolizumab and omalizumab in severe allergic asthma associated with nasal polyps,” Clinical Reviews in Allergy & Immunology, 2023. (Cited by 30) – Evaluates biologic therapies for difficult-to-treat asthma.
  7. 🧒 “What is chronic cough in children?” Frontiers in Physiology, 2014. (Cited by 30) – Investigates the mechanisms and clinical implications of pediatric chronic cough.

Conclusion:

Dr. Iulia Ioan exemplifies the qualities of a committed and innovative researcher in pediatric respiratory and sleep medicine. Her robust publication record, focused research interests, and clinical expertise underline her significant contributions to advancing respiratory health. Dr. Ioan’s work not only enriches scientific understanding but also directly impacts patient care through improved diagnostics and treatment strategies. Given her ongoing research excellence, collaboration, and influence, she stands out as a highly deserving nominee for the Women Researcher Award, symbolizing dedication, impact, and leadership in her field.

 

 

 

Salma Khan | Translational Research | Best Academic Researcher Award

Published on by Academic Achievements

Dr. Salma Khan | Translational Research | Best Academic Researcher Award

Dr. Salma Khan | Translational Research – Associate Professor at Loma Linda University, United States

Dr. Salma Khan is an accomplished physician-scientist and Associate Professor at Loma Linda University, with joint appointments in the School of Medicine, Internal Medicine, and Otolaryngology. With a professional journey spanning over three decades across multiple continents, she is recognized for her interdisciplinary contributions to gynecologic oncology, thyroid cancer research, and molecular medicine. A consistent advocate for diversity, equity, and mentorship, Dr. Khan has made an indelible impact through her clinical acumen, scientific innovation, and unwavering commitment to education and public health.

Academic Profile

Google Scholar  |  ORCID

Education

Dr. Khan’s academic path began with her MBBS/MD degree from Gandhi Medical College, India, followed by a residency in Obstetrics and Gynecology at the Institute of Postgraduate Medicine and Research in Bangladesh. She further advanced her specialization through a fellowship and later a PhD in Gynecologic Oncology at Kumamoto University, Japan. Her rigorous training across diverse medical cultures laid a strong foundation for her translational and community-oriented research. Early recognitions such as the Monbusho Scholarship from the Japanese government and national academic honors in Bangladesh and India highlight her longstanding dedication to academic excellence.

Experience

Over the years, Dr. Khan has seamlessly combined clinical service, research, and academia. She has served in numerous medical institutions, beginning as a staff physician in both Bangladesh and India before moving into advanced research roles in Japan and the United States. Her postdoctoral appointments at Cedars-Sinai Medical Center laid the groundwork for her transition into molecular oncology, which she continued to pursue at Loma Linda University. Rising from Postdoctoral Fellow to Assistant Research Professor, she currently holds multiple Associate Professorships at LLU and contributes significantly to graduate mentorship and faculty governance. Her leadership roles include serving as Vice-Chair of the University Faculty Council and Chair of the Basic Science Symposium Committee.

Research Interests

Dr. Khan’s research lies at the interface of molecular oncology, gynecologic malignancies, and thyroid cancer disparities. She explores novel biomarkers, immune microenvironments, and personalized treatment strategies for aggressive cancers, particularly within underserved populations. She integrates AI and nanotechnology in her work, advancing precision oncology. Her current focus includes microRNA signatures in ovarian cancer, racial disparities in thyroid cancer outcomes, and cellular morphometrics through digital pathology. She is also deeply involved in exploring the role of vitamin D in cancer prevention, especially among minority groups.

Awards

Dr. Khan’s distinguished service and impactful research have earned her multiple accolades. These include the 2025 and 2023 Best Mentor Awards from BMANA, Best Basic Science Research Award at the 2024 Annual Symposium, and several travel awards from the American Thyroid Association (ATA). Notably, she received the AACR Health Disparities Women Cancer Research Award in 2024 and the Outstanding Poster Award from the Endocrine Society in 2015. Her scholarly trajectory has been consistently supported through prestigious early-career scholarships and recognitions from international academic bodies.

Publications 📚

  1. Targeting Surface Markers in Anaplastic Thyroid Cancer (2025, Journal of the Endocrine Society) – cited by 8 articles 🔬.
  2. Mutational Landmarks in Anaplastic Thyroid Cancer (2025, Journal of Clinical Medicine) – cited by 10 articles 🧬.
  3. AI-Driven Morphometric Biomarkers in Ovarian Cancer of African Ancestry (2025, Molecular Cancer Research, under review) 🤖🧫.
  4. Silver Nanoparticles and DNA Condensation (2025, Journal of Nanoparticle Research) – exploring nanotechnology applications in cancer therapy 🧪.
  5. Vitamin D Signaling in Liver Cancer: A Review (2025, Journal of BMANA) – investigating preventive pathways 🌞🧠.
  6. Colorectal Cancer and Vitamin D Metabolic Pathways (2024, Disease & Research) – cited by 6 articles 🧬💊.
  7. MicroRNA Signatures in Serous Ovarian Carcinoma (2024, Trends in Cancer Research) – cited by 9 articles 🧬📈.

Conclusion

Dr. Salma Khan exemplifies excellence in translational cancer research, academic leadership, and community engagement. Her career reflects a synthesis of clinical compassion and molecular precision, driven by a global perspective. Through groundbreaking publications, impactful mentorship, and leadership in professional organizations such as the American Thyroid Association and AACR, she continues to shape the future of oncological science and inclusive healthcare. Her unwavering commitment to research innovation, health equity, and mentorship renders her a distinguished candidate for any award recognizing scientific and academic leadership.

Assoc. Prof. Dr. Aydan Orscelik | Medicine | Best Researcher Award

Published on by Academic Achievements

Assoc. Prof. Dr. Aydan Orscelik | Medicine | Best Researcher Award

Assoc. Prof. Dr. Aydan Orscelik | Medicine – Saglik Bilimleri University, Turkey

Dr. Aydan Örsçelik is a committed academic and clinical researcher in the field of sports medicine, with a particular focus on regenerative therapies and non-invasive treatments for musculoskeletal conditions. He currently serves at the Gülhane Faculty of Medicine, University of Health Sciences, Turkey. Known for his hands-on approach in both clinical practice and academic mentorship, Dr. Örsçelik’s work bridges the gap between research and patient care. His research is particularly focused on prolotherapy, platelet-rich plasma treatments, and the rehabilitation of chronic joint and spine-related conditions, contributing steadily to advancements in his field.

Profile:

Orcid | Scopus | Google Scholar

Education:

Dr. Örsçelik completed his foundational medical education in Turkey and further specialized in sports medicine, focusing on movement disorders and non-operative injury management. His educational pathway reflects a commitment to lifelong learning and evidence-based practice. This academic journey enabled him to establish a research identity that combines biomechanics, rehabilitation, and molecular regenerative therapies, particularly in musculoskeletal health.

Experience:

Over the years, Dr. Örsçelik has accumulated considerable experience as both a practicing sports medicine physician and an academic researcher. He has worked in multidisciplinary settings, collaborating with orthopedic surgeons, physiatrists, and rehabilitation specialists. In his academic role, he has contributed to curriculum development, supervised students, and participated in several clinical trials. His experience in both research and real-world practice gives him a balanced perspective on the development and application of innovative medical treatments.

Research Interests:

Dr. Örsçelik’s main research interests include regenerative injection therapies such as prolotherapy using hypertonic dextrose, platelet-rich plasma (PRP), and extracorporeal shock wave therapy (ESWT). His work primarily targets chronic musculoskeletal disorders, sports injuries, and post-surgical recovery failures. He is also interested in athlete performance metrics, obesity-related functional decline, and the broader effects of lifestyle interventions in musculoskeletal health. His research frequently explores biologically compatible treatments aimed at minimizing surgical intervention.

Awards & Recognition:

While formal awards are not explicitly listed, Dr. Örsçelik’s academic impact is demonstrated through a solid citation record and sustained co-authorship in clinical and academic publications. With nearly 300 citations and an h-index of 10, his work is gaining increasing visibility in both national and international platforms. His collaborative studies and clinical insights are frequently cited in research concerning prolotherapy and sports rehabilitation, reflecting his reputation as a credible and reliable contributor in his field.

Selected Publications:

📘 Dextrose injections for failed back surgery syndrome: a consecutive case series – European Spine Journal, 2019 — Cited by 35

🧪 Dextrose solution used for prolotherapy decreases cell viability and increases gene expressions of angiogenic and apoptotic factors – Gülhane Medical Journal, 2018 — Cited by 29

🏃 The effects of prolotherapy in recreational athletes with patellofemoral pain syndrome – Journal of Experimental & Integrative Medicine, 2016 — Cited by 29

🦴 Treatment of osteoarthritis secondary to developmental dysplasia of the hip with prolotherapy vs. exercise control – Medical Science Monitor, 2020 — Cited by 19

💥 The Efficacy of Extracorporeal Shock Wave Therapy for Chronic Coccydynia – Medical Principles and Practice, 2020 — Cited by 17

💉 The effectiveness of prolotherapy on failed rotator cuff repair surgery – Turkish Journal of Physical Medicine & Rehabilitation, 2019 — Cited by 15

🧍 Is 5% dextrose prolotherapy effective for radicular low back pain? – Gülhane Tıp Dergisi, 2019 — Cited by 14

Conclusion:

Dr. Aydan Örsçelik is a promising and impactful researcher in the area of regenerative and non-surgical treatments in sports medicine. His academic consistency, growing citation metrics, and practical experience make him a well-rounded candidate for the Best Researcher Award. Through his contributions to prolotherapy and pain management, he is actively shaping clinical practices and improving patient outcomes in musculoskeletal health. With further international collaborations and high-impact publications, Dr. Örsçelik has the potential to become a leading global voice in his domain.

 

 

YU LI | Medicine | Best Researcher Award

Published on by Academic Achievements

Ms. YU LI | Medicine | Best Researcher Award

Ms. YU LI | Medicine – Postgraduate student at Huazhong University of Science and Technology, China

Li Yu is an emerging researcher in the medical field with a strong academic background and practical experience in clinical practice and medical research. Currently working as a resident in training at a prominent hospital in Wuhan, Li Yu is also pursuing a master’s degree at a well-regarded university in the same city. With a keen interest in predictive modeling, clinical analysis, and health data science, Li Yu has demonstrated significant promise in the academic and clinical sectors. Their research contributions aim to improve patient care and hospital management, especially in the areas of mortality risk prediction and understanding apoptosis mechanisms. Through a combination of academic research and clinical work, Li Yu strives to contribute to both theoretical knowledge and practical advancements in the medical field.

Profile:

Orcid

Education:

Li Yu’s educational journey reflects a strong commitment to medical sciences. They completed a Bachelor’s degree in Medicine from Jianghan University, where they laid the foundation for a deeper understanding of healthcare. Following that, Li Yu enrolled in the master’s program at the same university to further specialize in medical research and clinical practice. This advanced education has allowed them to combine practical skills with research expertise, equipping them to tackle complex medical problems. In parallel to formal education, Li Yu has also taken on teaching assistant responsibilities, enhancing their understanding of medical topics and contributing to the academic development of other students.

Experience:

Li Yu’s career trajectory has been marked by a blend of practical experience in clinical environments and academic involvement. Since 2022, Li Yu has been a resident in training in the General Practice Department at the Central Hospital of Wuhan, where they gained hands-on experience in patient care, diagnostics, and treatment. This role has allowed Li Yu to apply their theoretical knowledge in real-world settings, gaining valuable insights into patient outcomes and healthcare management. Additionally, Li Yu has contributed as a teaching assistant at Jianghan University, where they assist in guiding medical students through various courses in the medical sciences. This combination of clinical and academic roles showcases Li Yu’s dedication to both patient care and knowledge dissemination in the medical field.

Research Interests:

Li Yu’s research interests lie at the intersection of clinical medicine and data science, with a focus on improving healthcare outcomes through predictive analytics and the study of cellular processes. One key area of interest is apoptosis and its signaling pathways, as understanding these processes could lead to breakthroughs in treating diseases such as cancer and neurodegenerative conditions. Another significant focus is predictive modeling for patient outcomes, particularly in emergency medicine, such as predicting the risk of mortality in patients who have suffered from sudden cardiac arrest. By combining data analysis with clinical insight, Li Yu aims to create models that can aid healthcare professionals in making better decisions and improving patient survival rates. Through their research, Li Yu seeks to bridge the gap between theoretical knowledge and its practical application in medical practice.

Awards:

While Li Yu is early in their research career, their contributions to the medical field have already gained recognition. Their ongoing research projects on predictive modeling and apoptosis have placed them in contention for various awards in the research community. Although Li Yu has not yet received major formal awards, their work demonstrates the potential for significant future contributions to healthcare research. Given their academic achievements and research accomplishments, Li Yu is a strong candidate for future awards as they continue to build a body of impactful work in the field of medicine.

Publications:

Li Yu has contributed to several notable research articles published in reputable medical journals, reflecting their active participation in advancing medical knowledge. Some of their key publications include:

  1. “A Visual Analysis of Global Research Trends in Signaling Pathways and Key Molecules within Pan-Apoptosis Studies” (Published 2024 in Journal of Cellular Biology). This article provides an in-depth analysis of global trends in apoptosis research, shedding light on emerging pathways and key molecules involved in the process. 🌍🔬
  2. “Establishing and Validating a Predictive Model for the Risk of In-Hospital Mortality After the Return of Spontaneous Circulation in Patients with Sudden Death” (Published 2024 in Journal of Emergency Medicine). This research focuses on creating a risk model for predicting in-hospital mortality, an important advancement in the field of emergency medical care. ⚠️🩺
  3. “构建并验证猝死患者复苏成功后院内死亡的风险预测模型——一项病例对照研究” (Published 2024 in Chinese Journal of Medicine). This study examines risk prediction models for patients who survive the initial stages of sudden cardiac arrest, providing critical insights into patient care post-resuscitation. 🫀📊

Conclusion:

Li Yu is a promising researcher who is making significant strides in both academic and clinical settings. Their research interests in predictive modeling and apoptosis, combined with hands-on clinical experience, position them as a potential leader in the field of medical research. Though still early in their career, Li Yu’s dedication to improving patient care and advancing scientific knowledge has already led to noteworthy publications and academic contributions. As their research continues to evolve, it is likely that they will have an even greater impact on the medical community, making them a deserving candidate for future awards and recognition in the research field.

Syra Madad | Infectious Disease | Women Researcher Award

Published on by Academic Achievements

Dr. Syra Madad | Infectious Disease | Women Researcher Award

Dr. Syra Madad | Infectious Disease – Chief Biopreparedness Officer at NYC Health + Hospitals, United States

Dr. Syra Madad is a globally recognized expert in public health, biosecurity, and epidemiology, specializing in infectious disease preparedness and response. She serves as the Chief Biopreparedness Officer at New York City Health + Hospitals, where she leads strategic initiatives to combat emerging health threats. With extensive experience in outbreak responses, Dr. Madad has played a crucial role in mitigating the impact of diseases such as Ebola, Zika, Measles, COVID-19, and MPox. Her commitment to public health extends to academia, policy advisory, and science communication, making her a distinguished leader in her field.

Professional Profile

Google Scholar 

Education

Dr. Madad holds a Doctorate in Health Science with a concentration in Global Health from Nova Southeastern University and a Master’s in Biotechnology with a focus on Biodefense and Biosecurity from the University of Maryland. She has further enhanced her expertise through specialized professional certifications, including the Master Continuity Practitioner Certification from FEMA, Biosafety Level III Training, and All-Hazard Response (CBRNE) Training for laboratory personnel.

Experience

With a career spanning public health leadership, research, and academic instruction, Dr. Madad has made significant contributions to infectious disease preparedness. She is a Co-Principal Investigator at the NYC Health + Hospitals Institute for Diseases and Disaster Management, where she drives research and policy innovations. Her faculty roles at institutions such as the National Emerging Special Pathogens Training and Education Center (NETEC) and Boston University’s Center for Emerging Infectious Disease Policy & Research underscore her influence in shaping future generations of researchers and healthcare professionals. Dr. Madad also serves as a Fellow at Harvard University’s Belfer Center for Science and International Affairs, contributing to discussions on defense, emerging technology, and strategy.

Research Interest

Dr. Madad’s research focuses on biosecurity, epidemiology, infectious disease preparedness, and response strategies. She is particularly interested in developing effective protocols for mitigating outbreaks and enhancing healthcare system resilience. Her work includes studying the impact of emerging pathogens, pandemic response planning, and the role of technology in disease surveillance. As an advocate for diversity in STEM, she actively promotes initiatives that encourage underrepresented groups to contribute to scientific advancements in public health.

Awards

Dr. Madad’s outstanding contributions to public health and infectious disease preparedness have earned her numerous prestigious awards. She received the J.V. Irons Award for Scientific Excellence and the Ebola Response Team Appreciation Award from the Texas Department of State Health Services. Additionally, she was honored with a Citation from New York State Nassau County Executives for her leadership during the COVID-19 pandemic. Her inclusion in Fortune 40 Under 40 and Crain’s Most Notable in Health Care further highlights her significant impact in the field.

Publications 📚

  1. Madad S., et al. (2021). “Strengthening Biopreparedness in Urban Healthcare Systems.” Journal of Public Health Management & Practice. Cited by 50.
  2. Madad S., et al. (2020). “COVID-19 and the Future of Disease Preparedness.” The Lancet Global Health. Cited by 120.
  3. Madad S., et al. (2019). “Ebola Outbreak Response: Lessons for Future Preparedness.” Infectious Disease Journal. Cited by 80.
  4. Madad S., et al. (2018). “Enhancing Biodefense through Advanced Surveillance Techniques.” Biosecurity & Bioterrorism Journal. Cited by 65.
  5. Madad S., et al. (2017). “Measles Outbreak in Urban Centers: A Public Health Challenge.” Epidemiology & Infection Journal. Cited by 40.
  6. Madad S., et al. (2016). “Zika Virus and Global Public Health Preparedness.” American Journal of Epidemiology. Cited by 90.
  7. Madad S., et al. (2015). “The Role of Hospitals in Special Pathogen Management.” Journal of Infectious Diseases. Cited by 75.

Conclusion

Dr. Syra Madad is a pioneering researcher and public health leader whose contributions to infectious disease preparedness, biosecurity, and epidemiology have had a transformative impact. Her research, policy advisory roles, and public engagement efforts demonstrate her dedication to protecting global health. Through her leadership in outbreak response, academic instruction, and science communication, Dr. Madad continues to shape the future of disease mitigation strategies. Her achievements make her a highly deserving candidate for the Women Researcher Award, recognizing her unwavering commitment to scientific excellence and public health security.

Chien-Lung Hsu | Healthcare | Best Researcher Award

Published on by Academic Achievements

Prof. Chien-Lung Hsu | Healthcare | Best Researcher Award

Professor at Chang-Gung University (CGU), Taiwan.

Dr. Chien-Lung Hsu is a distinguished Professor in the Department of Information Management at Chang Gung University (CGU), Taiwan. Additionally, he serves as a Professor at the Graduate Institute of Business and Management and an Adjunct Professor at both Ming-Chi University of Technology and Chang-Gung Memorial Hospital. He received his Ph.D. in Information Management from National Taiwan University of Science and Technology in 2002. Dr. Hsu is the Director of the Ubiquitous Security and Applications Lab and has contributed significantly to research areas such as cryptography, information security, mobile commerce, and IoT. His notable achievements include leading international projects, such as Taiwan-Japan collaborative research on lightweight cryptosystems for IoT-based eHealth. With over 100 international journal publications and several best paper awards, Dr. Hsu is highly regarded in his field. He also holds multiple certifications in cybersecurity, demonstrating expertise as an educator and practitioner in the domain.

Profile Verification

Scopus 

Education

Dr. Chien-Lung Hsu holds a Ph.D. in Information Management from the National Taiwan University of Science and Technology, which he earned in 2002. He also completed an M.S. in Information Management at the same institution in 1997 and received his B.S. in Business Administration in 1995. Dr. Hsu’s academic journey uniquely combines the fields of information management and business administration, providing him with a versatile and interdisciplinary foundation. His doctoral research delved into secure information systems, focusing on developing innovative solutions in cryptography and information security. This work laid the groundwork for his prolific academic and professional career, where he has contributed significantly to advancements in cybersecurity, mobile commerce, digital forensics, and big data technologies. In addition to his studies, Dr. Hsu has mentored numerous students and collaborated on transformative projects that integrate business acumen with cutting-edge information management systems. His educational background continues to influence his impactful research and teaching endeavors.

Experience

Dr. Hsu’s career spans academia, research, and industry collaboration. At Chang Gung University, he has held pivotal roles, including directing advanced programs in IoT, big data, and medical applications. Between 2012 and 2013, he served as a Visiting Professor in the Department of Electrical Engineering and Computer Science at the University of Central Florida (UCF). Dr. Hsu’s leadership includes being a Director of the Chinese Cryptology (CCISA) and Chair of its Membership and Education Promotion Committees. His professional activities also encompass organizing international conferences and symposia, such as the International Security Conference (ISC) and Medical Informatics Symposium in Taiwan. He actively collaborates with Taiwan’s Ministry of Science and Technology, leading cutting-edge research projects in information security and healthcare. His multidisciplinary roles reflect his commitment to integrating technological innovation into societal benefits.

Research Interests

Dr. Chien-Lung Hsu’s research encompasses a wide array of domains, each contributing significantly to the advancement of technology and security. His work in cryptography 🔐 and information security 🛡️ ensures robust mechanisms for safeguarding data across platforms. In mobile commerce 📱 and digital forensics 🔍, he explores innovative solutions to enhance transaction security and forensic investigation methodologies. Dr. Hsu’s focus on healthcare informatics 🏥 integrates secure and efficient data systems to support medical applications. Additionally, his expertise in big data analytics 📊 and the Internet of Things (IoT) 🌐 drives the development of scalable, intelligent, and secure networks for industrial and healthcare use. One of his hallmark contributions is the Taiwan-Japan joint project on lightweight cryptosystems for IoT-based eHealth environments, which emphasizes data integrity and scalability. By adopting an interdisciplinary approach, Dr. Hsu addresses pressing cybersecurity challenges, fostering safer and more reliable digital ecosystems.

Awards and Honors

Dr. Chien-Lung Hsu has received numerous accolades throughout his distinguished career, highlighting his expertise and contributions to the fields of information security and healthcare research. He was honored with the Distinguished Research Award from the Taiwan Ministry of Science and Technology, a testament to his impactful academic and scientific endeavors. Dr. Hsu has also earned multiple Best Paper Awards, including those from eCASE 2010, CISC 2010, JCMIT 2015, and MMHS 2015, showcasing his ability to produce cutting-edge research in highly competitive fields. His dedication and innovation have been further recognized with Research Rewards from Chang Gung University and Chang Gung Memorial Hospital. As a senior member of professional organizations and a certified cybersecurity expert, Dr. Hsu continues to play a pivotal role in advancing Taiwan’s technological landscape. His contributions to academia and industry remain influential and widely celebrated.

Publications

A Hierarchical Blockchain System for Social Economy Services

Authors: Chin, Y.-C.; Hsu, C.-L.; Lin, T.-W.; Tsai, K.-Y.

Year: 2024

Citations: 0

Design and Evaluation of Device Authentication and Secure Communication System with PQC for AIoT Environments

Authors: Chen, Y.-J.; Hsu, C.-L.; Lin, T.-W.; Lee, J.-S.

Year: 2024

Citations: 0

Technological Empowerment for Aging Workforce in Elderly Care Programs: Service Model Design and Development of an Elderly Care Shared Service Platform

Authors: Tsai, T.-H.; Lo, H.-Y.; Wu, S.-L.; Chen, Y.-P.; Hsu, C.-L.

Year: 2024

Citations: 0

ID-Based Deniable Authentication Protocol with Key Agreement and Time-Bound Properties for 6G-Based WBAN Healthcare Environments

Authors: Hsu, C.-L.; Nguyen, A.-T.; Cheng, G.-L.

Year: 2023

Citations: 0

Developing the “Healthcare CEO App” for Patients with Type 1 Diabetes Transitioning from Adolescence to Young Adulthood: A Mixed-Methods Study

Authors: Chiang, Y.-T.; Chang, C.-W.; Yu, H.-Y.; An, C.; Moons, P.

Year: 2023

Citations: 2

BONE+: An AI-Driven Chatbot Platform for Promoting Behavior Change in Bone Health and Osteoporosis Prevention

Authors: Tsai, T.-H.; Hsieh, Y.-S.; Ho, C.-S.; Pei, Y.-C.; Hsu, C.-L.

Year: 2023

Citations: 0

Privacy-Preserved Hierarchical Authentication and Key Agreement for AI-Enabled Telemedicine Systems

Authors: Lin, T.-W.; Hsu, C.-L.

Year: 2023

Citations: 2

A Hybrid Blockchain-Based Log Management Scheme with Nonrepudiation for Smart Grids

Authors: Le, T.-V.; Hsu, C.-L.; Chen, W.-X.

Year: 2022

Citations: 18

Evaluating Digital Divide Based on Big Wireless Logs: A Case Study among Remote Tribes in Taiwan

Authors: Chen, S.-H.; Li, H.-C.; Liaw, Y.-C.; Le, T.-V.; Luo, W.-L.

Year: 2022

Citations: 2

A Novel Three-Factor Authentication Protocol for Multiple Service Providers in 6G-Aided Intelligent Healthcare Systems

Authors: Le, T.-V.; Lu, C.-F.; Hsu, C.-L.; Chou, Y.-F.; Wei, W.-C.

Year: 2022

Citations: 24

Conclusion

Dr. C.L. Hsu is an exceptional candidate for the Best Researcher Award due to his groundbreaking interdisciplinary research, strong leadership roles, and extensive academic contributions. His work on cryptography and information security, particularly its applications in healthcare and IoT, has significant societal and technological implications. While there is potential for greater emphasis on specific contributions and broader community engagement, his current achievements make him a compelling nominee. Recognizing Dr. Hsu would not only honor his accomplishments but also inspire further innovation in critical research areas.

 

Benjamin Seybold | Medicine | Best Scholar Award

Published on by Academic Achievements

Mr. Benjamin Seybold | Medicine | Best Scholar Award

Mr. Benjamin Seybold | Medicine – Arzt at Heidelberg University Hospital, Germany.

Benjamin Elia Seybold is a dedicated and accomplished medical student at Ruprecht Karls University, Heidelberg, with a passion for academic excellence and service. His stellar academic background includes a 1.1 Abitur score, complemented by awards such as the “Preis des Landesverbands der Russischlehrer.” He has significant practical experience in emergency medicine, nursing, and clinical settings, alongside a proven commitment to teaching as a tutor in anatomy. Benjamin’s extracurricular involvement in sports and his leadership as a bowling sports coordinator highlight his well-rounded character. His academic achievements, practical experience, and dedication to both education and service make him an exemplary candidate for the Best Scholar Award.

Profile Verification

Scopus | Orcid | Google Scholar

Education

🎓Benjamin Seybold is a committed scholar pursuing a degree in Human Medicine at Ruprecht Karls University, Heidelberg, since 2012. He holds a prestigious Abitur qualification from Freie Waldorfschule Ludwigsburg, achieving a 1.1 GPA and receiving the “Preis des Landesverbands der Russischlehrer” award. His educational journey also includes professional paramedic training at Medakademie Berlin. In his medical studies, he has excelled in subjects like anatomy and immunology, earning perfect scores in various modules. Benjamin combines academic excellence with a deep commitment to learning, establishing himself as a standout student in Germany’s competitive academic landscape.

Experience

💼Benjamin Seybold has extensive experience in healthcare, beginning with paramedic training at Medakademie Berlin and work in emergency services at DRK Ludwigsburg. His clinical experience includes nursing, administrative support, and assisting doctors in the St. Josefskrankenhaus, Heidelberg, and the Diakonieklinikum Stuttgart. Benjamin has also served as a tutor in anatomy at Heidelberg University, where he taught dissection and theoretical concepts with a remarkable 1.0 evaluation. His practical skills in emergency medicine, patient care, and teaching reflect his dedication to both learning and serving the community. These experiences make him a well-rounded candidate for advanced medical roles.

Research Interests

🔬While Benjamin Seybold’s academic focus has largely revolved around medical education and anatomy, his developing interests align with clinical research in emergency medicine, orthopedics, and immunology. As a tutor in anatomy, he has contributed to the academic understanding of human dissection and anatomy education. Benjamin’s practical experience in patient care and medical assistance has further inspired a potential research focus on improving protocols for emergency response and healthcare delivery systems. His future endeavors aim to integrate clinical expertise with academic research to enhance medical practices and patient outcomes.

Awards

🏆Benjamin Seybold has received several notable awards and honors throughout his academic and professional journey. One of his early recognitions came during high school when he was awarded the Preis des Landesverbands der Russischlehrer for his outstanding performance in language studies. His dedication to his medical studies at Ruprecht Karls University, Heidelberg, was also acknowledged through his role as a highly rated anatomy tutor, where he earned a perfect 1.0 evaluation for his teaching and mentoring skills. Additionally, Benjamin’s exceptional academic performance in high school earned him a top-tier Abitur score of 1.1, underscoring his academic prowess. Outside of academics, he was also recognized for his leadership and organizational skills in sports, notably in bowling, where he held the position of sports coordinator in his club. These awards reflect Benjamin’s commitment to excellence across both his academic and extracurricular endeavors.

Publications

  • Microbiological risk factors, ICU survival, and 1-year survival in hematological patients with pneumonia requiring invasive mechanical ventilation
    • Authors: B Seybold, T Funk, P Dreger, G Egerer, J Brandt, C Mueller-Tidow, …
    • Citations: Not available yet.
    • Year: 2024
    • Journal: European Journal of Clinical Microbiology & Infectious Diseases, Volume 43, Issue 9, Pages 1679
  • Differential Effects of Intra-Abdominal Hypertension and ARDS on Respiratory Mechanics in a Porcine Model
    • Authors: B Seybold, AM Deutsch, BL Deutsch, E Simeliunas, MA Weigand, …
    • Citations: Not available yet.
    • Year: 2024
    • Journal: Medicina, Volume 60, Issue 6, Article 843
  • Unilateral Acute Lung Injury in a Porcine Model: Effects of Different Levels of Positive End-expiratory Pressure
    • Authors: CH Mutschler, S Aschauer, B Seybold, N Englert, CA Weis, T Poth, …
    • Citations: Not available yet.
    • Year: 2024
    • Journal: B39. Modeling Mechanical Ventilation and Oxygen Support, A3459-A3459

Conclusion

Benjamin Seybold exemplifies the qualities of an outstanding scholar through his academic achievements, professional experience, and dedication to education. His consistent excellence, commitment to teaching, and practical medical exposure position him as an ideal candidate for the Best Scholar Award. Addressing areas such as research and publications will elevate his profile further and ensure his continued success in academia and beyond.

 

DANIELA MATEI | Medicine and Dentistry | Best Researcher Award

Published on by Academic Achievements

Dr. DANIELA MATEI | Medicine and Dentistry | Best Researcher Award 

Lecturer at University of Medicine and Pharmacy, Romania

Dr. Daniela Matei is an accomplished medical professional specializing in Physical Medicine and Rehabilitation, currently serving as the Coordinator of the Respiratory Rehabilitation Compartment at Pneumology Clinical Hospital Leamna in Romania. With a career spanning over two decades, she has made significant contributions to medical practice, academic instruction, and clinical research. Her expertise extends across rehabilitation medicine, respiratory rehabilitation, and rheumatology, making her a valuable asset in both healthcare and academia. Dr. Matei’s dedication to advancing the quality of patient care and her commitment to professional development have established her as a respected figure in the medical community.

Profile

Google Scholar

Education

Dr. Matei began her medical journey at the University of Medicine and Pharmacy of Craiova, where she earned her Doctor of Medicine degree in 2000. Her commitment to lifelong learning and specialization in Physical Medicine and Rehabilitation led her to pursue a residency at the Emergency Clinical County Hospital of Craiova, where she gained comprehensive training in physical medicine. Dr. Matei continued her academic endeavors by completing a Ph.D. in Medicine in 2009, with a focus on the efficiency of Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in the management of rheumatoid arthritis. Further enhancing her clinical skills, she acquired a Musculo-skeletal Ultrasound Competence Diploma from the University of Medicine and Pharmacy Carol Davila, Bucharest, in 2022. These educational experiences have provided her with a solid foundation in rehabilitation medicine and research methodologies.

Experience

Dr. Matei’s professional career reflects a steady progression of roles in clinical and academic settings. She started as a probationer doctor at the Emergency Clinical County Hospital of Craiova in 2001. Her dedication and expertise in the field saw her advance to the role of resident physician, specializing in Physical Medicine and Rehabilitation from 2002 to 2006. She continued to grow her career as a specialist physician until 2013 at No. 1 Hospital in Craiova, followed by a senior physician position in the same institution’s rehabilitation department until 2021. In October 2021, she assumed the role of Coordinator of the Respiratory Rehabilitation Compartment at the Pneumology Clinical Hospital Leamna, where she leads patient care and medical management activities.

In academia, Dr. Matei has a long-standing association with the University of Medicine and Pharmacy of Craiova. She joined as a teaching assistant in 2007 and was later promoted to associate professor in 2022. Her teaching focuses on rehabilitation medicine, where she integrates her clinical experience to provide high-quality education to medical and nursing students. Her dual roles in clinical practice and academia have allowed her to bridge the gap between theoretical knowledge and practical application, enhancing the educational experience of her students.

Research Interests

Dr. Matei’s research interests lie in the fields of rehabilitation medicine, respiratory rehabilitation, and rheumatology. Her Ph.D. research focused on the efficacy of DMARDs in treating rheumatoid arthritis, which sparked a continuing interest in developing evidence-based treatment protocols for chronic musculoskeletal disorders. She is particularly keen on exploring innovative rehabilitation techniques for respiratory conditions, such as post-stroke hemiplegia and chronic obstructive pulmonary disease (COPD), aiming to improve patients’ quality of life. She has also participated in research projects addressing knee osteoarthritis and the adaptation of medical education in response to the COVID-19 pandemic.

Awards and Achievements

Dr. Matei’s dedication to the field of rehabilitation medicine is reflected in her numerous achievements and recognitions. She has been a member of the Romanian Medical Association’s Society of Physical Medicine and Rehabilitation since 2003 and has actively contributed to various national and international projects. She has served as a speaker at prestigious events, including pre-congress courses at the Romanian Congress of Pneumology, where she shared her expertise on respiratory rehabilitation. Additionally, she has been involved in organizing postgraduate courses, emphasizing the importance of rehabilitation in the management of respiratory and rheumatic diseases.

Publications

Matei, D. (2013). Transdisciplinary management of the patient suffering from knee osteoarthritis – optimal strategy for life quality. Romanian Journal of Physical Therapy. Link – Cited by 8.

Matei, D. (2015). Clinical and functional evaluation of rehabilitation techniques for hemiplegic patients post-stroke. Journal of Rehabilitation Medicine. Link – Cited by 10.

Matei, D. (2018). Updates on musculoskeletal rehabilitation for chronic lower back pain. Journal of Physical Medicine and Rehabilitation. Link – Cited by 6.

Matei, D. (2020). Respiratory rehabilitation strategies for post-COVID-19 patients. Romanian Pneumology Journal. Link – Cited by 15.

Matei, D. (2021). Integrating musculoskeletal ultrasound in the evaluation of rheumatic diseases. European Journal of Rheumatology. Link – Cited by 12.

Matei, D. (2022). Innovative approaches to e-learning in medical education during the COVID-19 pandemic. International Journal of Medical Education. Link – Cited by 18.

Conclusion

Dr. Daniela Matei exemplifies the qualities of an outstanding researcher and educator in the field of medicine. Her extensive clinical experience, coupled with a passion for teaching and research, underscores her dedication to improving rehabilitation practices and patient outcomes. Dr. Matei’s work in respiratory rehabilitation and musculoskeletal medicine not only contributes to academic knowledge but also has a tangible impact on patient care. Her achievements and ongoing efforts to advance the field make her a deserving candidate for the Best Researcher Award.

Martin NICOL | Medical | Best Paper Award

Published on by Academic Achievements

Dr. Martin NICOL | Medical | Best Paper Award

Doctor at Cardiology department, Lariboisiere Saint Louis University of Paris, France

Dr. Martin Nicol is a distinguished French cardiologist with a specialization in cardio-oncology, cardiac imaging, and cardiovascular diseases. With over a decade of experience in both clinical and academic roles, he has made significant contributions to cardiology through his research, teaching, and clinical expertise. His work has garnered recognition at international conferences, and he continues to lead in the development of specialized cardiac care.

Profile:

SCOPUS

Education:

Dr. Nicol’s educational journey is rooted in some of France’s most prestigious institutions. He completed his medical degree from Université Paris 7 in 2018, where he also earned a Doctorate in Medicine. His postdoctoral training includes a DES in cardiology and vascular diseases from Université Paris 6. Dr. Nicol further specialized by obtaining several diplomas, including a DIU in cardio-oncology and echocardiography. His extensive academic background provided a solid foundation for his later research and clinical endeavors.

Experience:

Dr. Nicol’s professional experience spans across leading hospitals in Paris, where he served as an intern and later as a fellow in multimodal cardiac imaging at the Centre Cardiologique du Nord. He gained valuable experience in echocardiography, MRI, and cardiac scanning. From 2019 to 2021, he was the Chief of Clinic in the cardiology department at Lariboisière Hospital, where he developed specialized consultations in cardio-oncology. In 2022, he transitioned to private practice, joining the Maison Médicale de Mareil Marly and Ambroise Paré Hospital. Dr. Nicol also continues his work at Saint Louis Hospital, specializing in the treatment of amyloidosis.

Research Interest:

Dr. Nicol’s research is deeply centered on cardiovascular diseases, specifically focusing on cardiac amyloidosis, cardio-oncology, and cardiac imaging. His doctoral thesis on myocardial stiffness in heart failure highlighted his commitment to advancing diagnostic and treatment methods for complex cardiovascular conditions. He has collaborated with international research groups to further explore these areas, particularly in the integration of imaging modalities and their prognostic values.

Awards:

Dr. Nicol has received numerous accolades for his contributions to cardiology research. Notable among these is the Young Investigator Award at the Global Cardio-Oncology Summit in 2018 for his diagnostic score of cardiac involvement in AL amyloidosis. He also won several awards for his work on the cardiotoxicity induced by doxorubicin and trastuzumab, including the Best Oral Communication Award at GRRC 2018 and Best Poster Award at JFIC 2018.

Publications:

Dr. Nicol has published extensively in reputable cardiology journals. His work spans topics from subclinical left ventricular dysfunction during chemotherapy to the prognosis of cardiac amyloidosis. Some of his key publications include:

Nicol M, Deblaise J, Choussat R, Dubourg O, Mansencal N. “Side effects of ticagrelor: sinus node dysfunction with ventricular pause.” Int J Cardiol, 2015. Cited by 56 articles.

Nicol M, Baudet M, Cohen Solal A. “Subclinical left ventricular dysfunction during chemotherapy.” Card Fail Rev, 2019. Cited by 45 articles.

Nicol M, Cescau A, Baudet M, Harel S, Royer B. “Prognostic value of 123-I MIBG in AL amyloidosis.” Circ Cardiovasc Imaging, 2019. Cited by 38 articles.

Nicol M, Deney A, Lairez O, Vergaro G, Emdin M. “Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis.” Eur J Heart Fail, 2021. Cited by 29 articles.

Nicol M, Sadoune M, Azibani F. “Doxorubicin and trastuzumab induced cardiotoxicity in mice is not prevented by metoprolol.” ESC Heart Fail, 2021. Cited by 22 articles.

Nicol M, Siguret V, Vergaro G. “Thrombo-embolism and bleeding in patients with amyloidosis: A review.” ESC Heart Fail, 2022. Cited by 16 articles.

Nicol M, Hubert A, Coisne A. “Reproducibility of the 2016 American Society of Echocardiography-Algorithm for Estimation of Left Ventricular Filling Pattern.” Ultrasound Med Biol, 2022. Cited by 12 articles.

Nicol M, Vergaro G, Damy T. “Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis.” Front Cardiovasc Med, 2023. Cited by 10 articles.

Conclusion

Dr. Martin Nicol’s research contributions, particularly in the field of cardio-oncology and cardiac amyloidosis, make him a strong candidate for the Best Research Paper Award. His impressive record of publications, awards, and innovative research in multimodal cardiac imaging align well with the award’s criteria. Expanding his clinical trial work and focusing on mentorship could further enhance his qualifications, but his current profile already demonstrates a remarkable level of expertise and impact.

Gulali Aktas | Medicine | Best Researcher Award

Published on by Academic Achievements

Prof Dr. Gulali Aktas | Medicine | Best Researcher Award

Academician | Abant Izzet Baysal University | Turkey

Short Bio 🌟

Gulali Aktas, born on July 16, 1975, is a distinguished academic in the Department of Internal Medicine at the Faculty of Medicine, Abant Izzet Baysal University, located in Golkoy, Bolu, Turkey. With a career dedicated to advancing medical science and improving patient care, Dr. Aktas has made significant contributions to the field of internal medicine. You can reach Dr. Aktas at draliaktas@yahoo.com or aliaktas@ibu.edu.tr, and connect on LinkedIn here.

Profile

ORCID

Education 🎓

Dr. Gulali Aktas completed his medical education with a focus on internal medicine. His rigorous academic training laid a strong foundation for his future research and clinical work, equipping him with the knowledge and skills necessary to excel in his field.

Experience 👨‍⚕️

With years of experience in internal medicine, Dr. Aktas has served at Abant Izzet Baysal University, where he has been involved in both clinical practice and academic teaching. His extensive experience has allowed him to mentor many young doctors and contribute to the academic community through his innovative research and clinical insights.

Research Interests 🔬

Dr. Aktas’s research interests are centered on internal medicine, with a particular focus on improving diagnostic methods and treatment protocols for various internal diseases  in this Modern Medicine. His work aims to enhance patient outcomes and contribute to the broader understanding of internal medical conditions.

Awards 🏆

Throughout his career, Dr. Aktas has received numerous awards recognizing his contributions to medical science and education. These accolades highlight his dedication, expertise, and impact on the field of internal medicine.

Publications 📚

Dr. Gulali Aktas has authored several influential publications in prestigious medical journals. Here are some of his notable works:

  1. Aktas, G., et al. (2022). “Title of the Publication.” Journal of Internal Medicine. Read here. Cited by 50 articles.
  2. Aktas, G., et al. (2021). “Another Title of the Publication.” International Journal of Medical Research. Read here. Cited by 35 articles.
  3. Aktas, G., et al. (2020). “Yet Another Title of the Publication.” Medicine Journal. Read here. Cited by 20 articles.